Keratopathy

Also known as: Keratopathy NOS

Drug	Drug Name	Drug Description
DB06151	Acetylcysteine	A medication that can be used as a mucolytic in patients with certain lung conditions and as an antidote for acetaminophen overdose.

Drug	Drug Name	Target	Type
DB06151	Acetylcysteine	Solute carrier organic anion transporter family member 1B1	transporter
DB06151	Acetylcysteine	NAPQI (N-acetyl-p-benzoquinone imine)	target
DB06151	Acetylcysteine	Solute carrier family 22 member 6	transporter
DB06151	Acetylcysteine	Aminoacylase-1	target
DB06151	Acetylcysteine	Inhibitor of nuclear factor kappa-B kinase subunit alpha	target
DB06151	Acetylcysteine	Inhibitor of nuclear factor kappa-B kinase subunit beta	target
DB06151	Acetylcysteine	Glutathione synthetase	target
DB06151	Acetylcysteine	Cystine/glutamate transporter	target
DB06151	Acetylcysteine	Glutamate receptor ionotropic, NMDA 2B	target
DB06151	Acetylcysteine	Glutamate receptor ionotropic, NMDA 1	target
DB06151	Acetylcysteine	Glutamate receptor ionotropic, NMDA 2A	target
DB06151	Acetylcysteine	Glutamate receptor ionotropic, NMDA 2D	target
DB06151	Acetylcysteine	Glutamate receptor ionotropic, NMDA 3A	target
DB06151	Acetylcysteine	Serum albumin	carrier
DB06151	Acetylcysteine	Aminoacylase-1	enzyme

Drug	Drug Name	Phase	Status	Count
DB00688	Mycophenolate mofetil	2 / 3	Unknown Status	1
DB00864	Tacrolimus	2 / 3	Unknown Status	1